Skip to content
Medical Health Aged Care

Microsoft Recommends Philips SpeechMike Premium Touch as the Successor to Nuance PowerMic

Speech Processing Solutions 2 mins read
VIENNA--BUSINESS WIRE--

Speech Processing Solutions, global leader in professional dictation solutions under the Philips brand, today announced that the Philips SpeechMike Premium Touch has been officially recognized by Microsoft as the recommended successor to the soon-to-be-retired Nuance PowerMic series.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507643740/en/

The Philips SpeechMike Premium Touch.

The Philips SpeechMike Premium Touch.

As the only microphone recommended by Microsoft for PowerMic replacement, the Philips SpeechMike Premium Touch delivers seamless, plug-and-play compatibility with many Nuance speech recognition solutions, including Dragon Medical One, Dragon Professional Anywhere, Dragon Legal Anywhere, and some versions of PowerScribe offering medical, legal and business professionals a superior alternative for uninterrupted documentation workflows.

With an intuitive button layout mirroring the PowerMic, the Philips SpeechMike Premium Touch offers users a familiar, yet enhanced dictation experience to enable effortless transitions. Already in use by millions of medical, legal and business professionals worldwide, the Philips SpeechMike Premium Touch offers:

  • Compatibility with Dragon Medical One, Dragon Professional Anywhere, Dragon Legal Anywhere, and some versions of PowerScribe, as well as other legacy software such as Dragon NaturallySpeaking, Dragon Medical Practice Edition, and Winscribe
  • Pre-configured Dragon function keys for convenient speech recognition control
  • Studio-quality microphone with noise reduction for unprecedented accuracy in speech recognition
  • Ergonomic design and hygienic housing, ideal for long-shift use and clinical work environments
  • Advanced touch sensor navigation replaces the need to switch to a mouse

“With the PowerMic now being retired in the coming weeks, organizations must move quickly to maintain continuity in documentation,” said Dr. Thomas Brauner, CEO at Speech Processing Solutions. “The Philips SpeechMike Premium Touch is delivering both familiarity and unprecedented quality in speech recognition accuracy. I am delighted to be able to offer the Philips SpeechMike – the leading and most widely used dictation microphone in the world – to all existing PowerMic users.”

The Philips SpeechMike Premium Touch is available now through professional distribution channels.

Speech Processing Solutions (SPS):

Speech Processing Solutions (SPS) is the global leader in AI-powered dictation and transcription solutions. Active in over 50 countries with more than 4 million users and a network of 1,000+ partners, SPS develops award-winning speech-to-text technologies and devices under the Philips brand. Headquartered in Vienna, Austria, SPS is globally active with offices in Australia, Canada, Belgium, France, Germany, the UK, and the US.


Contact details:

Press Contact:
Speech Processing Solutions
Alice Elt
Content & PR Manager
Email: [email protected]
www.philips.com/dictation | www.speechlive.com

Media

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTAN® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.